rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport
NCT ID: NCT01756144
Last Updated: 2015-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2015-07-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective is to study the effectivity of rhBmp-2 (inductos) to stimulate bone healing, in order to find new techniques to treat non-union of long bones.
The method of the study is a randomized controlled trial, to compare rhBMP-2 and autologous bone grafting in stimulating bone healing in the docking site.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
rhBMP-2 Versus Autograft in Critical Size Tibial Defects
NCT00853489
A Randomized Controlled Cost Study of Infuse BMP 2 vs Iliac Crest Autograft for Non Union of Long Bone Fractures
NCT00856479
Effect of rhBMP-2 or rhBMP-7 on Long Bone Fractures and Non-unions.
NCT05065684
OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions
NCT00679328
Treatment of Atrophic Nonunion by Preosteoblast Cells
NCT00916981
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Autologous bone grafting
autologous bone of the iliac crest
rhBMP-2
rhBMP-2
Inductos, recombinant human bone morphogenetic protein
rhBMP-2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rhBMP-2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* active growth,
* malignancy
* infection
* PAD
* pathological fracture
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Jan Vanderstappen
MD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-005664-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.